Genetic Variation For Parkinson's Disease Identified

An international team of researchers led by neuroscientists at Mayo Clinic in Florida has said that they have discovered a genetic variation that protects against Parkinson's disease.

The gene variants cut the risk of developing the disease by nearly 20 percent in many populations.

Parkinson’s Disease - Causes, Symptoms, Diagnosis, Treatment
Parkinson’s disease is a neurodegenerative disease caused by progressive dopamine brain cells loss. Symptoms of Parkinson’s disease are correctable to an extent.

The study also reported the discovery of different variants of the same gene, LRRK2- the most important Parkinson's risk gene found to date - that double Parkinson's risk in Caucasians and Asians.

In addition, the finding provides evidence that Parkinson's disease is influenced by multiple genetic risks that act together to cause disease.

"The idea that Parkinson's disease occurs mostly in a random sporadic fashion is changing," said lead investigator Owen Ross, Ph.D., a neuroscientist at Mayo Clinic Florida.

New Imaging Test to Diagnose Parkinson's Disease
A new diagnostic imaging technique has been developed by researchers to evaluate patients for parkinsonian syndromes.

"Our study, one of the largest to date in the study of the genetics of Parkinson's disease, shows that a single gene, LRRK2, harbours both rare and common variants that in turn alter the susceptibility to PD in diverse populations," he stated.

Researchers hope to use these and future genetic findings to predict who is at risk of Parkinson's and to develop novel targeted therapies, Dr. Ross added.

Doctors Need to Better Screen Parkinson�s Patients For Deep Brain Stimulation Therapy
While deep brain stimulation has gained recognition by referring physicians as a treatment for Parkinson's disease and other movement disorders

The study has been published in the online Aug. 31 issue of Lancet Neurology.

Source-ANI

New Therapeutic Doors to Parkinson's Disease Opened by Protein Find
A protein key to Parkinson's disease has likely been mischaracterized as a natively unfolded protein that lacked structure, a new study has discovered.